New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 25, 2014
13:13 EDTMRVL, LRCX, MU, MNK, AAPL, RAD, QCOREinhorn bought Lam Research shares, sold Rite Aid last quarter
Well-known investor David Einhorn said his hedge fund, Greenlight Capital, had taken a new long position last quarter in Lam Research (LRCX), which develops equipment for semiconductor companies. Also last quarter, Greenlight sold out of its position in Rite Aid (RAD), Einhorn revealed. WHAT'S NEW: Greenlight made a "medium-sized" new investment in Lam Research, Einhorn revealed in his quarterly letter to investors. As the size of transistors shrink, chip makers must run each layer of chips through the manufacturing line multiple times until they work properly, the investor stated. Consequently, the chip makers must buy more of Lam's tools for each manufacturing line, Einhorn explained. The valuations of many high momentum stocks in the tech sector are excessive, but not all tech stocks are too expensive, Einhorn contended. A number of tech stocks - including Apple (AAPL), Lam Research, Marvell Technology (MRVL) and Micron Technology (MU) - "have strong prospects and are undervalued," Einhorn declared. Greenlight holds long positions in all those stocks. Greenlight sold its position in Rite Aid because the company's sales and profits rose, as the hedge fund had expected, and the stock reached fair value, Einhorn explained. WHAT'S NOTABLE: Greenlight continues to be short Questcor (QCOR), which has "a laundry list of problems and risks," the investor said. Among these are ongoing criminal probes and a large number of adverse events, including deaths, experienced by a number of patients who were taking the company's only drug, Acthar, Einhorn wrote. Additionally, a number of insurers have moved towards limiting their reimbursement of the drug, he added. The FDA is examining lab reports which suggest that Questcor's product does not include a highly purified form of Acthar as promoted by the company but a degraded form of the drug, the investor alleged. Mallinckrodt Pharmaceuticals (MNK), which has agreed to buy Questcor, is not properly evaluating the risks of Questcor's drug, Einhorn stated. Mallinckrodt "is setting itself up to be a very attractive short sale candidate if the merger is completed," Einhorn believes. PRICE ACTION: In early afternoon trading, Lam Research lost 1.5% to $69, Rite Aid slid 3.5% to $7, Questcor lost 2% to $95, and Mallinckrodt dropped 3% to $74.50.
News For LRCX;RAD;MNK;QCOR;AAPL;MU;MRVL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
November 12, 2014
16:00 EDTAAPLOptions Update; November 12, 2014
Subscribe for More Information
09:37 EDTAAPLActive equity options trading
Active equity options trading according to Track Data: AAPL CLSN TWTR BABA NFLX TSLA AMZN CSIQ C
06:36 EDTAAPLOrder visibility highest for Apple, Lenovo shipments in 2015, DigiTimes says
Subscribe for More Information
05:51 EDTMUMicron checks show stonger than expected DDR4 demand, says Piper Jaffray
Subscribe for More Information
November 11, 2014
16:01 EDTAAPLOptions Update; November 11, 2014
Subscribe for More Information
13:09 EDTAAPLApple to face lawsuit on failed texts when switching to Android, Reuters says
Apple must face a U.S. federal lawsuit for failing to alert consumers that text messages may be interrupted after switching to an Android-based phone from an iPhone, says Reuters. Reference Link
09:55 EDTAAPLAlibaba, Apple working out details on partnership in China, WSJ reports
Subscribe for More Information
09:37 EDTAAPLActive equity options trading
Subscribe for More Information
08:15 EDTAAPLAlibaba says willing to collaborate with PayPal in future, Bloomberg reports
Subscribe for More Information
07:35 EDTAAPLApple price target raised to $125 from $115 at UBS
Subscribe for More Information
06:31 EDTAAPLApple making aggressive move into corporate market, Reuters says
Subscribe for More Information
06:03 EDTAAPLQ4 global tablet shipments estimated at 74.5M units, DigiTimes reports
Subscribe for More Information
November 10, 2014
16:00 EDTAAPLOptions Update; November 10, 2014
Subscribe for More Information
15:16 EDTMUMicron to increase Japan investment to up DRAM output, Nikkei says
Subscribe for More Information
12:42 EDTAAPLFireEye details hack attack found on Apple operating system
Subscribe for More Information
12:39 EDTAAPLFireEye has uncovered iOS flaw that leaves devices vulnerable, CNBC reports
Subscribe for More Information
09:35 EDTAAPLActive equity options trading
Subscribe for More Information
07:34 EDTAAPLApple Pay seen making up 1% of Whole Foods transactions since launch, Dudas says
Subscribe for More Information
06:27 EDTAAPLGT Advanced accuses Apple of 'bait-and-switch' in unsealed documents, WSJ says
Subscribe for More Information
06:00 EDTAAPLApple implied volatility of 19 at lower end of index mean range
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use